Inovio Pharmaceuticals, Inc. (INO) is a publicly traded Healthcare sector company. As of May 21, 2026, INO trades at $1.27 with a market cap of $100.37M and a P/E ratio of -0.69. INO moved +2.46% today. Year to date, INO is -22.64%; over the trailing twelve months it is -42.25%. Its 52-week range spans $1.03 to $6.04. Analyst consensus is buy with an average price target of $4.50. Rallies surfaces INO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Inovio Pharmaceuticals, Inc. (INO) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. INO moved +2.46% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $1.27 |
| Market Cap | $100.37M |
| P/E Ratio | -0.69 |
| EPS | $-1.81 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.04 |
| 52-Week Low | $1.03 |
| Volume | 2.36M |
| Avg Volume | 0 |
| Revenue (TTM) | $65.34K |
| Net Income | $-84.95M |
| Gross Margin | 0.00% |
2 analysts cover INO: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $4.50.